Search
Axsome Therapeutics Inc
AXSMAdd to Watchlist
207.780USD
-6.500-3.03%
Close 09-18 16:00（ET）
10.87BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.03%
5 Days
-5.88%
1 Month
-4.78%
6 Months
+30.78%
Year to Date
+13.76%
1 Year
+79.20%
Key Figures
212.050Open
213.265High
33.12KVolume
LossP/E TTM
34.99P/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
214.280Prev. Close
206.920Low
6.93MTurnover
LossP/E Static
130.54P/B
0.00%Div Yield TTM
-28.74%ROA
260.19052wk High
0.04Volume Ratio
-287.22MNet Profit
52.30MShares
-3.7270EPS TTM
0.60Beta
-349.38%ROE
114.91052wk Low
2.37%Amplitude
92.32%Gross Margin
10.87BMarket Cap
-1.48Reward/Risk
2.74%Risk Rate
Axsome Therapeutics Inc's Score
0.12vs previous score
Forecast8.64
Financial Health8.40
Technical4.24
Valuation Dimensions9.70
Institutional Confidence7.00
Risk Assessment7.00
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Axsome Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.99/-0.84
Revenue / Forecast
218.38M/221.23M
Axsome Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolAXSM
Number of employees683
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Antecip Capital, L.L.C. | 14.27% |
| BlackRock Institutional Trust Company, N.A. | 6.31% |
| Vanguard Portfolio Management, LLC | 4.00% |
| Vanguard Capital Management, LLC | 3.77% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 38.35% |
| Investment Advisor/Hedge Fund | 22.15% |
| Corporation | 14.27% |
| Hedge Fund | 9.36% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Axsome Therapeutics Inc (AXSM)?
The current price of Axsome Therapeutics Inc (AXSM) is 207.78.
What is the symbol of Axsome Therapeutics Inc?
The ticker symbol of Axsome Therapeutics Inc is AXSM.
What is the 52-week high of Axsome Therapeutics Inc?
The 52-week high of Axsome Therapeutics Inc is 260.19.
What is the 52-week low of Axsome Therapeutics Inc?
The 52-week low of Axsome Therapeutics Inc is 114.91.
What is the market capitalization of Axsome Therapeutics Inc?
The market capitalization of Axsome Therapeutics Inc is 10.87B.
Is Axsome Therapeutics Inc (AXSM) currently rated as Buy, Hold, or Sell?
According to analysts, Axsome Therapeutics Inc (AXSM) has an overall rating of Buy, with a price target of 279.29.
What is the Earnings Per Share (EPS TTM) of Axsome Therapeutics Inc (AXSM)?
The Earnings Per Share (EPS TTM) of Axsome Therapeutics Inc (AXSM) is -3.73.